首页 | 本学科首页   官方微博 | 高级检索  
检索        

联检端粒酶活性和DNA异倍体诊断恶性腹水
引用本文:王秀蕊,钟怀印,张建华,薛承岩,白海洋.联检端粒酶活性和DNA异倍体诊断恶性腹水[J].中国误诊学杂志,2007,7(4):685-686.
作者姓名:王秀蕊  钟怀印  张建华  薛承岩  白海洋
作者单位:1. 河北省兴隆县医院,067000
2. 承德医学院附属医院
3. 上海复星医药(集团)股份有限公司
基金项目:河北省卫生厅二OO五医学科学研究重点课题计划项目(编号:05310)
摘    要:目的:评价联检端粒酶活性(TA)和DNA异倍体诊断恶性腹水的价值。方法:良、恶性腹水各57份,应用端粒重复序列扩增-杂交-酶联免疫分析法检测TA、流式细胞术检测DNA异倍体。结果:恶性腹水TA及DNA异倍体的阳性率为84.2%及73.7%,联检TA和DNA异倍体的阳性率为94.7%。结论:联检TA和DNA异倍体可进一步提高诊断恶性腹水的敏感性,更有益于良、恶性腹水的鉴别,联检的临床价值高于单一试验。

关 键 词:腹水/诊断  端粒  末端转移酶/代谢  非整倍性
文章编号:1009-6647(2007)04-0685-02
收稿时间:2006-12-16
修稿时间:2007-01-15

Combined Determination of Telomerase Activity and DNA Aneuploid in Ascites for Diagnosis of Malignant Ascites
WANG Xiu-rui,ZHONG Huai-yin,ZHANG Jian-hua,et al..Combined Determination of Telomerase Activity and DNA Aneuploid in Ascites for Diagnosis of Malignant Ascites[J].Chinese Journal of Misdiagnostics,2007,7(4):685-686.
Authors:WANG Xiu-rui  ZHONG Huai-yin  ZHANG Jian-hua  
Abstract:Objective:To appraise the value on combined determination of telomerase activity(TA) and DNA aneuploid for the diagnosis of malignant ascites.Methods:Telomeroc repeat amplification protocol-hybridism-enzyme-linked immunosorbent assay and Flow cytometry were used to detect TA and DNA aneuploid in 57 cases of malignant ascites and 57 cases of benign ascites.Results:The positive rates of TA and DNA aneuploid were 84.2% and 73.7%.The positive rates about combined determination of TA and DNA aneuploid was 94.7%.Conclusion:Combined determination of TA and DNA aneuploid can make further improvement on the sensibility for the diagnosis of malignant ascites and the clinical value of combined index is higher than single index.
Keywords:Ascites/diagnosis  Telomerase/metabolism  Aneuploidy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号